Publications by authors named "Ron Vergona"

Claim this Profile
N
Novel P2Y12 adenosine diphosphate receptor antagonists for inhibition of platelet aggregation (II): pharmacodynamic and pharmacokinetic characterization.
Joseph M Post, Serene Alexander, Yi-Xin Wang, Jon Vincelette, Ron Vergona

Thromb Res· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thiophene-anthranilamides as highly potent and orally available factor Xa inhibitors.
Bin Ye, Damian O Arnaiz, Yuo-Ling Chou, Brian D Griedel, Rushad Karanjawala, Ron Vergona

J Med Chem· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
3
3-Mercaptopropionic acids as efficacious inhibitors of activated thrombin activatable fibrinolysis inhibitor (TAFIa).
Imadul Islam, Judi Bryant, Karen May, Raju Mohan, Shendong Yuan, Ron Vergona

Bioorg Med Chem Lett· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Substituted thiophene-anthranilamides as potent inhibitors of human factor Xa.
Monica J Kochanny, Marc Adler, Janice Ewing, Brian D Griedel, Elena Ho, Ron Vergona

Bioorg Med Chem· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, synthesis, and activity of 2-imidazol-1-ylpyrimidine derived inducible nitric oxide synthase dimerization inhibitors.
David D Davey, Marc Adler, Damian Arnaiz, Keith Eagen, Shawn Erickson, Ron Vergona

J Med Chem· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, synthesis, and biological activity of novel factor Xa inhibitors: 4-aryloxy substituents of 2,6-diphenoxypyridines.
Howard P Ng, Brad O Buckman, Keith A Eagen, William J Guilford, Monica J Kochanny, Ron Vergona

Bioorg Med Chem· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis